ATHENA: Natural History of Disease Study in Alport Syndrome Patients

Clinical trial NCT02136862 · COMPLETED

Trial details

NCT number: NCT02136862
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Study type: OBSERVATIONAL

Alport Syndrome Patients With eGFR Between 45-90 ml/Min/1.73 m2

Start date: 2014-09-04
Primary completion: 2017-12-18
Enrollment: 165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.